Stifel Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$270K Sell
12,148
-692
-5% -$16.5K ﹤0.01% 3253
2025
Q4
$343K Buy
+12,840
New +$307K ﹤0.01% 3071
2020
Q3
Sell
-21,804
Closed -$1.06M 2874
2020
Q2
$1.06M Buy
21,804
+766
+4% +$36.8K ﹤0.01% 1517
2020
Q1
$886K Sell
21,038
-6,351
-23% -$262K ﹤0.01% 1515
2019
Q4
$1.17M Buy
27,389
+20,964
+326% +$912K ﹤0.01% 1707
2019
Q3
$227K Buy
+6,425
New +$195K ﹤0.01% 2589
2018
Q4
Sell
-11,656
Closed -$244K 2657
2018
Q3
$244K Buy
+11,656
New +$183K ﹤0.01% 2472
2017
Q4
Sell
-7,373
Closed -$279K 2647
2017
Q3
$279K Sell
7,373
-225
-3% -$7.32K ﹤0.01% 2189
2017
Q2
$209K Sell
7,598
-1,110
-13% -$33.1K ﹤0.01% 2321
2017
Q1
$302K Buy
8,708
+260
+3% +$9.18K ﹤0.01% 2085
2016
Q4
$242K Sell
8,448
-2,150
-20% -$56.9K ﹤0.01% 2166
2016
Q3
$334K Sell
10,598
-468
-4% -$15.9K ﹤0.01% 1935
2016
Q2
$359K Buy
+11,066
New +$370K ﹤0.01% 1945

Other funds holding ACAD